Fitness&Life, NUTRITION, BCAATON, OPTIMUM, APITONUS, ECDISTON, ANTI DEPRESSION, GOLD HEALER, KARDIOTON, EROMAX, KILO LIGHT, HONDRO-VIT, MEMO-VIT,

WIPO WIPO 2018

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark Fitness&Life, NUTRITION, BCAATON, OPTIMUM, APITONUS, ECDISTON, ANTI DEPRESSION, GOLD HEALER, KARDIOTON, EROMAX, KILO LIGHT, HONDRO-VIT, MEMO-VIT, was filed as Figurative mark on 03/15/2018 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Quadrilaterals #Letters presenting a special form of writing #Colours #Rectangles #Several quadrilaterals juxtaposed, joined or intersecting #Quadrilaterals containing one or more circles, ellipses or polygons (specify the content) #Quadrilaterals containing one or more other geometrical figures (specify the content) #Quadrilaterals containing one or more letters #Quadrilaterals with dark surfaces or parts of surfaces #Letters in relief or shaded #Series of letters in different dimensions #Letters in light-coloured characters on a dark background #Five colours and over

Trademark Details Last update: January 6, 2023

Trademark form Figurative mark
File reference 1407487
Countries Australia European Community Georgia India Japan South Korea Mexico New Zealand Turkey United States of America (USA) Uzbekistan Armenia Azerbaijan China Kazakhstan Moldova Ukraine
Base trademark RU No. 2017753227, December 14, 2017
Application date March 15, 2018
Expiration date March 15, 2028

Trademark owner

ul. Sverdlova, d. 4, g. Penza
440026
RU

Trademark representatives

ul. Lenina, d. 63. kv. 32, g. Krasnogorsk 143408 Moscow oblast RU

goods and services

05 Amino acids for medical purposes; medicine cases, portable, filled; first-aid boxes, filled; mineral food supplements; nutritional supplements; albumin dietary supplements; yeast dietary supplements; alginate dietary supplements; glucose dietary supplements; casein dietary supplements; lecithin dietary supplements; linseed oil dietary supplements; propolis dietary supplements; protein dietary supplements; royal jelly dietary supplements; pollen dietary supplements; wheat germ dietary supplements; linseed dietary supplements; enzyme dietary supplements; yeast for pharmaceutical purposes; gelatine for medical purposes; cod liver oil; medicinal roots; starch for dietetic or pharmaceutical purposes; blood for medical purposes; cultures of microorganisms for medical or veterinary use; liquorice for pharmaceutical purposes; lactose for pharmaceutical purposes; candy for medical purposes; drugs for medical purposes; medicines for human purposes; powdered milk for babies; royal jelly for pharmaceutical purposes; milk ferments for pharmaceutical purposes; Irish moss for medical purposes; flour for pharmaceutical purposes; linseed meal for pharmaceutical purposes; mint for pharmaceutical purposes; dietetic beverages adapted for medical purposes; medicinal infusions; tinctures for medical purposes; decoctions for pharmaceutical purposes; pectin for pharmaceutical purposes; pepsins for pharmaceutical purposes; peptones for pharmaceutical purposes; food for babies; biological preparations for medical purposes; pharmaceutical preparations; chemico-pharmaceutical preparations; chemical preparations for pharmaceutical purposes; albuminous foodstuffs for medical purposes; dietetic foods adapted for medical purposes; by-products of the processing of cereals for dietetic or medical purposes; pharmaceuticals; sedatives; laxatives; digestives for pharmaceutical purposes; tonics [medicines]; nervines; media for bacteriological cultures; serums; antioxidant pills; appetite suppressant pills; slimming pills; jujube, medicated; medicinal tea; herbal teas for medicinal purposes; eucalyptus for pharmaceutical purposes; plant extracts for pharmaceutical purposes; elixirs [pharmaceutical preparations]; ethers for pharmaceutical purposes; esters for pharmaceutical purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes

Trademark history

Date Document number Area Entry
January 3, 2023 2023/1 Gaz US Rejection
October 4, 2021 2021/45 Gaz IN RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 16, 2020 2020/14 Gaz UZ RAW: Rule 18ter(2)(i) GP following a provisional refusal
January 24, 2020 2020/5 Gaz AM RAW: Rule 18ter(2)(i) GP following a provisional refusal
January 7, 2020 2020/3 Gaz US Rejection
December 18, 2019 2020/2 Gaz KZ Rejection
November 14, 2019 2019/50 Gaz AZ RAW: Rule 18ter(2)(i) GP following a provisional refusal
November 14, 2019 2019/47 Gaz MD RAW: Rule 18ter(2)(i) GP following a provisional refusal
October 17, 2019 2019/43 Gaz UZ Rejection
October 1, 2019 2019/40 Gaz UA RAW: Rule 18ter(2)(ii) GP following a provisional refusal
July 12, 2019 2021/2 Gaz GE Rejection
July 12, 2019 2019/30 Gaz AM Rejection
July 11, 2019 2019/29 Gaz KR Rejection
July 9, 2019 2019/31 Gaz AU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
June 27, 2019 2019/26 Gaz JP Rejection
June 11, 2019 2019/25 Gaz AZ Rejection
June 10, 2019 2019/25 Gaz KZ Rejection
May 30, 2019 2019/22 Gaz MD Rejection
March 21, 2019 2019/12 Gaz UA Rejection
February 20, 2019 2019/8 Gaz MX Rejection
January 3, 2019 2019/14 Gaz AU Rejection
January 3, 2019 2019/3 Gaz CN Rejection
December 11, 2018 2018/50 Gaz NZ Rejection
November 20, 2018 2018/47 Gaz EM Rejection
October 25, 2018 2018/43 Gaz US Rejection
July 23, 2018 2018/31 Gaz IN Rejection
June 9, 2018 2018/26 Gaz Correction
March 15, 2018 2018/22 Gaz RU Registration

ID: 141407487